Announcements Trials
Browse Landscape

Phase

Phase 2 44Phase 3 12Phase NA 6Phase 4 4Phase 2/3 3Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Completed 3

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Polycystic Ovary Syndrome 1Kallmann Syndrome 1Hypogonadism 1Hyperprolactinemia 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Gonadotropin-Releasing Hormone × Clear all
NCT01420250 2025-05-15

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Thomas Jefferson University

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT00914823 2024-07-31

Kisspeptin Administration in the Adult

Massachusetts General Hospital

Phase 1 Completed
256 enrolled

Hyperprolactinemia, Hypogonadism, Polycystic Ovary Syndrome, Kallmann Syndrome

NCT00099086 2024-01-31

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Medical University of South Carolina

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡